Eesti Biotehnoloogia Liit - International Projects

International Projects

EBio is currently participating in two international projects:

Realisation of Young Innovative Company Status, YIC, for biotech companies.

The aim of this project is to develop a common plan for realisation of Young Innovative Company (YIC) status in four Nordic/Baltic countries and to disseminate the experience gained to biotech organisations in other parts of Europe. One of the possible definitions of YIC is “small and medium-sized enterprises, which

(a) are less than 15 years old

(b) have less than 250 employees

(d) spend at least 15% of their total annual expenditure on R&D

The activities of the project include:

formulation of national expert groups (Task Forces)
conducting a benchmarking study on tax incentives in Canada, France, Norway and Great Britain.
the results of the research as well as further progress are presented at a high-level seminar.
As a conclusion a common implementation plan will be designed, which will be disseminated through a manual, guidelines, a handbook for policy makers and a public web site.

The project partners are Swedish Institute for Food and Biotechnology, SwedenBio, EBio, Norwegian Process Industries, Chemical Industry Federation in Finland, EuropaBio, France Biotech. The duration of the project is 24 months starting from October 2005.

The results of the benchmarking study (presentation)

The results of the benchmarking study (detailed)

YIC project website

For more information contact biotech [at] biotech.ee

From GMP to GBP: Fostering Good Bioethical Practices among European Biotechnology Industry

The project aims at improving understanding of bioethical issues by using the daily practise of biotechnology companies, involving the industry into defining the principles of bioethics and developing a methodology of approaching ethic issues.

During the project a survey of daily bioethical paractises among European biotechnology companies will be carried out. The results will be discussed in a series of seminars with experts, regulatory agencies and policy-makers and patient organisations. As a result, the bioethical guidelines will be updated for the industry and recommendations set for European legislators.

The project partners are France Biotech, National Institute for Health and Medical Research (France), EuropaBio, SwedenBio, EBio and Hungarian Biotechnology Association. The project’s duration is 24 months starting from September 2006.

For more information contact biotech [at] biotech.ee

« Tagasi